Federal award
SL MEDITECH CO.
W81K0223P0102
Contract
Obligated and Ceiling
- Obligated (net)
- $252,870.00
- Ceiling (potential value, not spending)
- $252,870.00
- Current value
- $252,870.00
- Gross positive obligations
- $252,870.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SL MEDITECH CO. · S92AR7KEA4U1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SL MEDITECH CO. · S92AR7KEA4U1
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0223P0102
- Award type code
- B
- Actions
- 10 · Aug 29, 2023 to Apr 15, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 15, 2026 | FY2026 | P00009 | M | $0.00 | — |
| Apr 3, 2026 | FY2026 | P00008 | M | $0.00 | — |
| Dec 19, 2025 | FY2026 | P00007 | C | $82,560.00 | — |
| Aug 8, 2025 | FY2025 | P00006 | G | $0.00 | — |
| Apr 30, 2025 | FY2025 | P00005 | M | $0.00 | — |
| Oct 16, 2024 | FY2025 | P00004 | M | $82,560.00 | — |
| Sep 24, 2024 | FY2024 | P00003 | G | $0.00 | — |
| Nov 9, 2023 | FY2024 | P00002 | C | $81,000.00 | — |
| Sep 6, 2023 | FY2023 | P00001 | G | $0.00 | — |
| Aug 29, 2023 | FY2023 | 0 | — | $6,750.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.